John P. Longenecker Ph.D., Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 2,000 shares at $28.49 ($57K) on 2013-03-28, disclosed to the SEC on 2013-04-01.
Scheduled sale ($57k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | SELL | 2019-12-04 | $60K | — | Filing → |
| ALRN | BUY | 2018-08-14 | $25K | — | Filing → |
| PCRX | BUY | 2016-01-14 | $20K | — | Filing → |